Outlook Therapeutics to Present at the Virtual BIO Investor Forum Digital
MONMOUTH JUNCTION, N.J., Oct. 07, 2020 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the […]
Further Progress on ‘Route to Market’ for Lake Giles Iron Project
RCR Mining Technologies (“RCR MT”) completes engineering design report to support the potential development of a cutting-edge ‘Helix’ rail car […]
Aprea Therapeutics Receives OK from FDA to Initiate Phase 1 Clinical Studies for Next-Generation Mutant p53 Reactivator, APR-548
BOSTON, Oct. 07, 2020 (GLOBE NEWSWIRE) — Aprea Therapeutics Inc., (NASDAQ: APRE), a clinical-stage biotechnology company focused on developing and […]
